Positives? There's heaps! - Nextstellis is going to be 'paradigm changing' even though Roger Corbett can't pronounce it properly (he goes with Nextsellis). - Roger kept hinting at another jv that was in the pipline that was going to be great for the company. - Resubmission of generic Nuvaring application to FDA should hopefully be 'quite early in the new year' (no mention of any expected approval date anymore though). - Contract services is doing well - Revenue is only down by 9%. Could almost count that as a win because of Covid according to Scott Richards. - We're all working really hard and doing our best - both Roger and Scott.
MYX Price at posting:
36.0¢ Sentiment: Sell Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)